Developing a Nomogram for Predicting Colorectal Cancer and Its Precancerous Lesions Based on Data from Three Non-Invasive Screening Tools, APCS, FIT, and sDNA

References

• Baidoun F, Elshiwy K, Elkeraie Y, et al. Colorectal cancer epidemiology: recent trends and impact on outcomes. Curr Drug Targets. 2021;22(9):998–1009. doi:10.2174/1389450121999201117115717
   PubMed Web of Science ®Google Scholar
• Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250–281. doi:10.3322/caac.21457
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for Colorectal Cancer Screening. Gastroenterology. 2020;158(2):418–432. doi:10.1053/j.gastro.2019.06.043
   PubMed Web of Science ®Google Scholar
• Betesh AL, Schnoll-Sussman FH. Colorectal Cancer Screening in the Elderly. Clin Geriatr Med. 2021;37(1):173–183. doi:10.1016/j.cger.2020.08.012
   PubMed Web of Science ®Google Scholar
• Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol. 2022;19(8):521–531. doi:10.1038/s41575-022-00612-y
   PubMed Web of Science ®Google Scholar
• Ze Y, Tu H, Zhang L, et al. A comparison of single and combined schemes of Asia-Pacific colorectal screening, faecal immunochemical and stool deoxyribonucleic acid testing for community colorectal cancer screening. J Multidiscip Healthc. 2023;16:571–586. doi:10.2147/JMDH.S398997
   PubMed Web of Science ®Google Scholar
• Luu XQ, Lee K, Kim J, Sohn DK, Shin A, Choi KS. The classification capability of the Asia Pacific colorectal screening score in Korea: an analysis of the cancer screenee cohort. Epidemiol Health. 2021;43:e2021069. doi:10.4178/epih.e2021069
   PubMed Web of Science ®Google Scholar
• Yeoh KG, Ho KY, Chiu HM, et al.; Asia-Pacific Working Group on Colorectal Cancer. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60(9):1236–1241. doi:10.1136/gut.2010.221168
   PubMed Web of Science ®Google Scholar
• Meklin J, Syrjänen K, Eskelinen M. Colorectal cancer screening with traditional and new-generation fecal immunochemical tests: a critical review of fecal occult blood tests. Anticancer Res. 2020;40(2):575–581. doi:10.21873/anticanres.13987
   PubMed Web of Science ®Google Scholar
• Xu J, Rong L, Gu F, et al. Asia-Pacific colorectal screening score combined with stool DNA test improves the detection rate for colorectal advanced neoplasms. Clin Gastroenterol Hepatol. 2022;S1542–S3565(22):00874. doi:10.1016/j.cgh.2022.09.002
   Google Scholar
• Aniwan S, Rerknimitr R, Kongkam P, et al. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants. Gastrointest Endosc. 2015;81(3):719–727. doi:10.1016/j.gie.2014.11.035
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–80. doi:10.1016/S1470-2045(14)71116-7
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhang X, Cui G, Qi X, Jiang Z, Yu L. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer. Cancer Med. 2024;13(10):e7296. doi:10.1002/cam4.7296
   PubMed Web of Science ®Google Scholar
• Zhan Y, Wang S, Yuan Z, et al. The stool syndecan2 methylation test is more robust than blood tests for methylated septin9, CEA, CA19-9 and CA724: a diagnostic test for the early detection of colorectal neoplasms. Transl Cancer Res. 2023;12(1):65–77. doi:10.21037/tcr-22-1710
   PubMed Web of Science ®Google Scholar
• Digestive Endoscopy Special Committee of Endoscopic Physicians Branch of Chinese Medical Association; Cancer Endoscopy Committee of China Anti-Cancer Association. 中华消化内镜诊疗相关肠道准备指南 (2019 上海) [Chinese guideline for bowel preparation for colonoscopy (2019, Shanghai)]. Zhonghua Nei Ke Za Zhi, 2019; 58(7):485–495. doi:10.3760/cma.j.issn.0578-1426.2019.07.002
   PubMedGoogle Scholar
• Wang J, Liu S, Wang H, et al. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study. Clin Clin Epigenet. 2020;12(1):162. doi:10.1186/s13148-020-00954-x
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Wu J, Lu L, Chen H, et al. Prognostic nomogram to predict the overall survival of patients with early-onset colorectal cancer: a population-based analysis. Int J Colorectal Dis. 2021;36(9):1981–1993. doi:10.1007/s00384-021-03992-w
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu C, Hu J, et al. Investigating the risk factors for nonadherence to analgesic medications in cancer patients: establishing a nomogram model. Heliyon. 2024;10(7):e28489. doi:10.1016/j.heliyon.2024.e28489
   PubMed Web of Science ®Google Scholar
• Ye C, Leslie WD. Fracture risk and assessment in adults with cancer. Osteoporos Int. 2023;34(3):449–466. doi:10.1007/s00198-022-06631-4
   PubMed Web of Science ®Google Scholar
• Tepus M, Yau TO. Non-Invasive Colorectal Cancer Screening: an Overview. Gastrointest Tumors. 2020;7(3):62–73. doi:10.1159/000507701
   PubMed Web of Science ®Google Scholar
• Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171. doi:10.7326/M13-1484
   PubMed Web of Science ®Google Scholar
• Bosch LJW, Melotte V, Mongera S, et al. Multitarget stool DNA test performance in an average-risk colorectal cancer screening population. Am J Gastroenterol. 2019;114(12):1909–1918. doi:10.14309/ajg.0000000000000445
   PubMed Web of Science ®Google Scholar
• Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012;142(2):248–56; quiz e25–6. doi:10.1053/j.gastro.2011.10.031
   Web of Science ®Google Scholar
• Anderson JC, Robinson CM, Hisey W, Limburg PJ, Butterly LF. Colonoscopy findings in FIT+ and mt-sDNA+ patients versus in colonoscopy-only patients: new hampshire colonoscopy registry data. Cancer Prev Res. 2022;15(7):455–464. doi:10.1158/1940-6207.CAPR-21-0581
   PubMed Web of Science ®Google Scholar
• Park YS, Kim DS, Cho SW, et al. Analysis of syndecan-2 methylation in bowel lavage fluid for the detection of colorectal neoplasm. Gut Liver. 2018;12(5):508–515. doi:10.5009/gnl17357
   PubMed Web of Science ®Google Scholar
• Oh TJ, Oh HI, Seo YY, et al. Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer. Clin Clin Epigenet. 2017;9:126. doi:10.1186/s13148-017-0426-3
   PubMed Web of Science ®Google Scholar
• Li W, Zhang L, Hao J, et al. Validity of APCS score as a risk prediction score for advanced colorectal neoplasia in Chinese asymptomatic subjects: a prospective colonoscopy study. Medicine. 2016;95(41):e5123. doi:10.1097/MD.0000000000005123
   PubMed Web of Science ®Google Scholar
• Mo S, Wang H, Han L, et al. Fecal multidimensional assay for non-invasive detection of colorectal cancer: fecal immunochemical test, stool DNA mutation, methylation, and intestinal bacteria analysis. Front Oncol. 2021;11:643136. doi:10.3389/fonc.2021.643136
   PubMed Web of Science ®Google Scholar